Closed · RFA-GH-21-006 · CFDA 93.326 · Discretionary

Strengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

up to $2M
Award range
Closed
Status
February 22, 2021
Close date
6
Expected awards

The verdict

Strengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered Up to $2,000,000 across 6 expected awards. Future funding cycles may be published under the same CFDA number.

up to $2M
award range
Closed
application status
6
expected awards
93.326
CFDA program

Opportunity snapshot. This Grants.gov announcement - Strengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally - is cataloged under number RFA-GH-21-006 and tied to CFDA assistance listing 93.326, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on November 16, 2020 and last updated on December 21, 2020. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is Up to $2,000,000. The agency has projected $60.0 million in total estimated funding for this announcement. It expects to issue 6 awards. If the agency funds the expected 6 awards from the $60.0 million estimated pool, the average award works out to roughly $10.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on February 22, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Up to $2,000,000

Close Date

February 22, 2021

Although a letter of intent is not required, is not binding, and does not enter the review of a subsequent application, the information that it contains allows CIO staff to estimate the potential review workload and plan the review. Prospective applicants are encouraged to submit a letter of intent by the date listed in Part 1. “Overview Information”, that includes the following information: Name of the Applicant Descriptive title of proposed research Applicant should state which countries they plan to work in in Year 1 (maximum 2) Name, address, and telephone number of the PD(s)/PI(s) Names of other key personnel Participating institutions Countries where proposed work is expected to be conducted Number and title of this funding opportunity announcement The letter of intent should be emailed to: Dr. Sheila Okoth Scientific Program Official, Email: jyo3@cdc.gov Extramural Research Program Office Office of the Associate Director of Science Center for Global Health Centers for Disease Control and Prevention U.S. Department of Health and Human Services 1600 Clifton Road, MS D-69 Atlanta, GA 30333 Telephone: 404-718-4405 Fax: 404-639-7490 Email: jyo3@cdc.gov To ensure receipt please send LOI as an e-mail only.

Posted

November 16, 2020

Est. Total Funding

$60,000,000

Expected Awards

6

Instrument

Cooperative Agreement

Description

The purpose of this notice of funding opportunity is to: • Conduct and monitor epidemiologic and laboratory-based science, surveillance, and research related to COVID-19 and other global public health threats in Africa, Southeast Asia, Eastern Europe and Central Asia, and the Middle East and North Africa (MENA), including, but not limited to, assessments of the extent of pathogen exposures or transmission based on serologic testing, improved understanding of immune responses to infectious pathogens, and assessments of various approaches to collecting and analyzing the results of serologic testing; and, • Incorporate the results of these public health activities into operational disease detection, prevention, and response or control programs in regions noted above, strengthen public health capacity as outlined in the Global Health Security Agenda, and disseminate findings across the region, with partners, and globally.

Eligibility

Grants.gov lists this opportunity under eligibility category codes 06, 12, 20, 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Lata Kumar lkumar@cdc.gov

Key Dates

Posted November 16, 2020
Close Date February 22, 2021
Archive Date March 24, 2021
Last Updated December 21, 2020

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Strengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally", offered by Centers for Disease Control and Prevention - ERA. It is associated with CFDA program 93.326. The purpose of this notice of funding opportunity is to: • Conduct and monitor epidemiologic and laboratory-based science, surveillance, and research related to COVID-19 and other global public health...
Is this opportunity still open?
No, this opportunity is closed. It closed on February 22, 2021. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Up to $2,000,000. Total estimated funding: $60,000,000. Expected number of awards: 6.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants